REGENXBIO announces proposed public offering of common stock
REGENXBIO announced it intends to offer and sell $175,000,000 of its common stock in an underwritten public offering. REGENXBIO intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares sold in connection with the offering. August 09, 2018